pimagedine has been researched along with Acquired Facial Neuropathy in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yanilmaz, M | 1 |
| Akduman, D | 1 |
| Sagun, ÖF | 1 |
| Haksever, M | 1 |
| Yazicilar, O | 1 |
| Orhan, I | 1 |
| Akpolat, N | 1 |
| Gök, U | 1 |
1 other study available for pimagedine and Acquired Facial Neuropathy
| Article | Year |
|---|---|
The effects of aminoguanidine, methylprednisolone, and melatonin on nerve recovery in peripheral facial nerve neurorrhaphy.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Facial Nerve Diseases; Female; Guanidines; Melat | 2015 |